Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial()

BACKGROUND: To investigate if a 5-day course pivmecillinam (amdinocillin pivoxil) 400 mg three times daily is superior to a 3-day course in women with uncomplicated urinary tract infection (UTI). METHODS: A randomised, double-blind, placebo-controlled trial conducted at nine primary care centres in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansåker, Filip, Thønnings, Sara, Hertz, Frederik Boëtius, Kallemose, Thomas, Værnet, Jan, Bjerrum, Lars, Benfield, Thomas, Frimodt-Møller, Niels, Knudsen, Jenny Dahl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677655/
https://www.ncbi.nlm.nih.gov/pubmed/31388664
http://dx.doi.org/10.1016/j.eclinm.2019.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677655/
https://www.ncbi.nlm.nih.gov/pubmed/31388664
http://dx.doi.org/10.1016/j.eclinm.2019.06.009

Ejemplares similares